Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Matthew R. Lordo
Observed names:
Matthew Lordo,
Matthew R Lordo
Institution:
The Ohio State University
Observed institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University
ORCID:
0000-0002-7108-9765
Observed ORCID:
0000-0002-7108-9765
OpenAlex ID:
A5015732486
Single-cell RNA sequencing identifies a population of human liver-type ILC1s
2023
·
Benjamin Krämer
, Ansel P. Nalin
, et al.
·
Cell Reports
·
39
PDF
Unraveling the Role of Innate Lymphoid Cells in Acute Myeloid Leukemia
2021
·
Matthew R. Lordo
, Steven D. Scoville
, et al.
·
Cancers
·
12
PDF
Acute Myeloid Leukemia Alters Group 1 Innate Lymphoid Cell Differentiation from a Common Precursor
2021
·
Matthew R Lordo
, Kevin G Wu
, et al.
·
The Journal of Immunology
·
11
Effects of epigenetic therapy on natural killer cell function and development in hematologic malignancy
2023
·
Matthew R Lordo
, Andrew R Stiff
, et al.
·
Journal of Leukocyte Biology
·
6
PDF
Adipocyte CD1d Gene Transfer Induces T Cell Expansion and Adipocyte Inflammation in CD1d Knockout Mice
2022
·
Run Xiao
, Anthony G Mansour
, et al.
·
The Journal of Immunology
·
6
Leukemia-driven expansion of type 3 innate lymphoid cell facilitates a pro-tumoral microenvironment in acute myeloid leukemia
2025
·
Thanh Thanh T. Dinh
, Matthew R. Lordo
, et al.
·
Leukemia
·
2
PDF
Type 3 Innate Lymphoid Cells Promote Acute Myeloid Leukemia Immune Evasion and Expansion
2023
·
Thanh Thanh (Sarah) T Dinh
, Matthew Lordo
, et al.
·
Blood
·
1
CD200R1 Distinguishes Uncommitted Precursors from Functionally Mature NK Cells within the Human Tonsil Stage 4A NK Cell Population
2021
·
Youssef Youssef
, Ansel P. Nalin
, et al.
·
Blood
·
1
A patient with concurrent EBV-negative diffuse large B-cell lymphoma and angioimmunoblastic T-cell lymphoma: a case report
2024
·
Monika A. Satoskar
, Matthew R. Lordo
, et al.
·
Frontiers in Hematology
PDF
Data from Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma
2023
·
Bethany L. Mundy-Bosse
, Christoph Weigel
, et al.
Supplementary Data from Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma
2023
·
Bethany L. Mundy-Bosse
, Christoph Weigel
, et al.
Supplementary Figure from Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma
2023
·
Bethany L. Mundy-Bosse
, Christoph Weigel
, et al.
Supplementary Data from Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma
2023
·
Bethany L. Mundy-Bosse
, Christoph Weigel
, et al.
Data from Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma
2023
·
Bethany L. Mundy-Bosse
, Christoph Weigel
, et al.
Supplementary Figure from Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma
2023
·
Bethany L. Mundy-Bosse
, Christoph Weigel
, et al.
PDF
Supplementary Data from Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma
2023
·
Bethany L. Mundy-Bosse
, Christoph Weigel
, et al.
Supplementary Data from Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma
2023
·
Bethany L. Mundy-Bosse
, Christoph Weigel
, et al.
PDF
Type 3 Innate Lymphoid Cells Protect Leukemic Blasts from Natural Killer Cell Cytotoxicity in Acute Myeloid Leukemia
2022
·
Matthew R Lordo
, Thanh T Dinh
, et al.
·
Blood
ILC3 Expansion in Acute Myeloid Leukemia
2022
·
Thanh Thanh Trinh Dinh
, Matthew R Lordo
, et al.
·
The Journal of Immunology
Show more works
View as search
Works count:
19
Citation count:
78
H-index:
5
I10-index:
3
Year
Topic
Type
